Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma

Archives of Dermatological Research

Volumn 298, Issue 8, 2007, Pages 371-379

  Mössner, Rotraut ^a   Anders, Nils ^a   König, Inke R ^c   Krüger, Ullrich ^a   Schmidt, Diane ^a   Berking, Carola ^b   Ziegler, Andreas ^c   Brockmöller, Jürgen ^a   Kaiser, Rolf ^a   Volkenandt, Matthias ^b   Westphal, Götz A ^a   Reich, Kristian ^a,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d DERMATOLOGIKUM HAMBURG   (Germany)

Author keywords

Genetics; GST; MC1R; Melanoma; Risk

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MELANOCORTIN 1 RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CELL COUNT; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE DELETION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GERMANY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLEX POLYMERASE CHAIN REACTION; NEVUS CELL; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; EYE COLOR; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HAIR COLOR; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SKIN NEOPLASMS;

EID: 33845496518     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-006-0708-7     Document Type: Article

References (39)

1. Bataille V (2000) Genetics of familial and sporadic melanoma. Clin Exp Dermatol 25:464-470
2. Bataille V (2003) Genetic epidemiology of melanoma. Eur J Cancer 39:1341-1347
3. Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, Lucier GW (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect 98:113-117
4. Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos SS I, Swerdlow AJ, Bishop DT, Newton Bishop JA (2004) An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype. J Invest Dermatol 122:429-432
5. Blankenburg S, König IR, Mössner R, Laspe P, Thoms KM, Krüger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S (2005) Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 26:1085-1090
6. Burchill SA, Ito S, Thody AJ (1993) Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. J Endocrinol 137:189-195
7. Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, Garcia-Cabezas MA, Vara JA, Dominguez-Caceres A, Perona R, Gonzalez-Baron M (2004) Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15:707-719
8. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102:695-699
9. Hill HZ, Hill GJ (2000) UVA, pheomelanin and the carcinogenesis of melanoma. Pigment Cell Res 13:140-144
10. Holland EA, Schmid H, Kefford RF, Mann GJ (1999) CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 25:339-348
11. Ichii-Jones F, Lear JT, Heagerty AH, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Davies E, Ollier WE, Thomson W, Yengi L, Bath J, Fryer AA, Strange RC (1998) Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol 111:218-221
12. Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, I Dos SS, Beswick S, Bishop DT, Newton Bishop JA (2005) No Evidence for BRAF as a melanoma/nevus susceptibility gene. Cancer Epidemiol Biomarkers Prev 14:913-918
13. Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR (2001) Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 10:509-513
14. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294-300
15. Kerb R, Brockmoller J, Reum T, Roots I (1997) Deficiency of glutathione S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 108:229-232
16. Kerb R, Brockmoller J, Schlagenhaufer R, Sprenger R, Roots I, Brinkmann U (2002) Influence of GSTT1 and GSTM1 genotypes on sunburn sensitivity. Am J Pharmacogenomics 2:147-154
17. La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217:53-60
18. Lear JT, Smith AG, Strange RC, Fryer AA (2000) Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 142:8-15
19. Lee EY, Williamson R, Watt P, Hughes MC, Green AC, Whiteman DC (2006) Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis. Int J Cancer (in press)
20. Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkötter C, Armstrong C, Ansel J (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917:232-238
21. Matichard E, Verpillat P, Meziani R, Gerard B, Descamps V, Legroux E, Burnouf M, Bertrand G, Bouscarat F, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, Lanternier G, Lebbe C, Crickx B, Grandchamp B, Soufir N (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41:e13
22. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
23. Moral A, Palou J, Lafuente A, Molina R, Piulachs J, Castel T, Trias M (1997) Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. MMM Group. Multidisciplinary Malignant Melanoma Group. Br J Dermatol 136:345-50
24. Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C (2005) Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control 16:893-899
25. Naysmith L, Waterston K, Ha T, Flanagan N, Bisset Y, Ray A, Wakamatsu K, Ito S, Rees JL (2004) Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. J Invest Dermatol 122:423-428
26. Neumann AG, Nagaeva O, Mandrika I, Petrovska R, Muceniece R, Mincheva-Nilsson L, Wikberg JE (2001) MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126:441-446
27. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176-186
28. Panizzon RG, Guggisberg D (1999) [Clinical aspects and pathology of melanoma]. Ther Umsch 56:302-308
29. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276
30. Rees JL (2004) The genetics of sun sensitivity in humans. Am J Hum Genet 75:739-751
31. Reich K, Westphal G, Schulz T, Muller M, Zipprich S, Fuchs T, Hallier E, Neumann C (1999) Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 113:214-220
32. Robinson SJ, Healy E (2002) Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21:8037-8046
33. Royston P, Altman DG (1994) Regression using fractional polynomials of continuous covariats: Parsimonious parametric modelling. Appl Stat 43:429-467
34. Sanchez-Laorden BL, Sanchez-Mas J, Martinez-Alonso E, Martinez-Menarguez JA, Garcia-Borron JC, Jimenez-Cervantes C (2006) Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J Invest Dermatol 126:172-181
35. Shanley SM, Chenevix-Trench G, Palmer J, Hayward N (1995) Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma. Carcinogenesis 16:2003-2004
36. Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG (2003) The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16:266-272
37. Sturm RA, Teasdale RD, Box NF (2001) Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277:49-62
38. Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW (2001) Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22:403-408
39. Ziegler AK, König IR (2006) A statistical approach to genetic epidemiology. Concepts and applications. Wiley-VCH, Weinheim